Retrospective multicenter study finds an MRI radiomic and clinical model predicts cognitive decline in Parkinson's disease, highlighting its value for early intervention.
Background To develop and validate a T1-weighted imaging (T1WI)-based radiomic signature and integrate it with clinical features to construct a combined model for the early identification of cognitive decline in Parkinson’s disease (PD). Methods We retrospectively analyzed data from 233 PD patients, including 182 from the Parkinson’s Progression Markers Initiative (PPMI) and 51 from the National Alzheimer’s Coordinating Center (NACC). Based on baseline Montreal Cognitive Assessment (MoCA) scores, patients were classified into those with normal cognition (PD-NC) and those with mild cognitive impairment (PD-MCI). The PPMI cohort was randomly divided into training ( n = 127) and test ( n = 55) sets at a 7:3 ratio, while the NACC cohort served as an external validation set ( n = 51). Radiomic features were extracted from T1WI of the bilateral basal ganglia (globus pallidus, putamen) and bilateral thalamus. After dimensionality reduction, a radiomic model was constructed. Independent clinical predictors were identified and integrated with the radiomic signature to establish a combined model. Model performance was evaluated using receiver operating characteristic (ROC) curves, confusion matrices, and F1-scores. SHapley Additive exPlanations (SHAP) was employed to interpret model outputs. Results The radiomic model achieved area under the curve (AUC) values of 0.809, 0.777, and 0.776 in the training, test, and external validation sets, respectively. Multivariable regression identified the Geriatric Depression Scale (GDS) score (odds ratio [OR] = 1.41, P = 0.005) and resting tremor (OR = 4.11, P = 0.036) as independent predictors. The combined model incorporating these clinical factors with the radiomic signature yielded significantly improved AUCs of 0.848 (95% CI: 0.774–0.906), 0.796 (95% CI: 0.666–0.893), and 0.812 (95% CI: 0.628–0.925) across the three datasets, outperforming either model alone. Among the 13 retained radiomic features, texture features were predominant (69.2%). SHAP analysis confirmed that the Rad-score was the most influential predictor. Conclusion The combined model integrating T1WI-based radiomic features from the bilateral basal ganglia (globus pallidus, putamen)–thalamus with clinical characteristics demonstrates robust predictive capability for cognitive decline in PD. This approach offers valuable support for early intervention and precision management in clinical practice.
No takes yet. Share an insight, caveat, or question.
Jian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: